Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $175 at UBS; Remains Sidelined

June 13, 2017 8:54 AM
UBS raised its price target on Amgen (NASDAQ: AMGN) to $175.00 (from $174.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles